Dr Lisa Dwane
This person is a member of Sanger Institute Alumni.
Lisa joined the Translational Cancer Genomics team in September 2019, following completion of her PhD studies in the Royal College of Surgeons in Ireland.
Lisa’s research is focused on the identification of novel cancer drug combinations in cancer types with an unmet clinical need, such as KRAS-mutant colorectal and triple-negative breast cancers. This will be acheived using a next generation dual guide CRISPR/Cas9 system to idenitify novel genetic interactions across multiple cancer cell lines.